Safety and Efficacy of AEB071 in Metastatic Uveal Melanoma Patients
NCT01430416
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
153
Enrollment
INDUSTRY
Sponsor class
Conditions
Uveal Melanoma
Interventions
DRUG:
AEB071
Sponsor
Novartis Pharmaceuticals